HLVXHilleVax, Inc.

Nasdaq hillevax.com


$ 12.14 $ 0.01 (0.08 %)    

Friday, 31-May-2024 15:59:49 EDT
QQQ $ 454.82 $ -0.01 (-0 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.59 (0.88 %)
TLT $ 91.26 $ 0.69 (0.77 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 12.14
$ 12.00
$ 0.00 x 0
$ 0.00 x 0
$ 11.81 - $ 12.45
$ 9.94 - $ 20.22
180,858
na
492.87M
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-20-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-17-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 06-08-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-hillevax-raises-price-target-to-24

JP Morgan analyst Eric Joseph maintains HilleVax (NASDAQ:HLVX) with a Overweight and raises the price target from $21 to $24.

 hc-wainwright--co-reiterates-buy-on-hillevax-maintains-28-price-target

HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.

 hillevax-q1-2024-adj-eps-097-misses-084-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.84) by...

 hc-wainwright--co-reiterates-buy-on-hillevax-maintains-28-price-target

HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.

 recap-hillevax-q4-earnings
Recap: HilleVax Q4 Earnings
03/20/2024 21:30:28

 hillevax-q4-2023-gaap-eps-078-beats-083-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.83) by 6...

 hc-wainwright--co-initiates-coverage-on-hillevax-with-buy-rating-announces-price-target-of-28

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and announce...

 guggenheim-maintains-buy-on-hillevax-lowers-price-target-to-34

Guggenheim analyst Seamus Fernandez maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $38 to $34.

 stifel-maintains-buy-on-hillevax-lowers-price-target-to-30

Stifel analyst Stephen Willey maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $35 to $30.

 hillevax-q3-eps-081-beats-084-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.84) by 3...

 why-hillevax-shares-are-trading-lower

HilleVax Inc (NASDAQ: HLVX) shares are trading lower by 8.5% to $13.20 Wednesday morning after the company announced pricing of...

 hillevax-intends-to-offer-and-sell-100m-of-shares-of-its-common-stock-in-public-offering

 In addition, HilleVax expects to grant the underwriters a 30-day option to purchase up to an additional $15.0 million of share...

 jp-morgan-maintains-overweight-on-hillevax-lowers-price-target-to-22

JP Morgan analyst Eric Joseph maintains HilleVax (NASDAQ:HLVX) with a Overweight and lowers the price target from $23 to $22.

 hillevax-q1-earnings-insights
HilleVax: Q1 Earnings Insights
05/12/2023 21:10:10

 hillevax-q1-eps-071-beats-094-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.94) by 2...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION